Motus GI Holdings, a medical device company, filed a $29 million initial public offering with the Securities Exchange Commission Jan. 5, Renaissance Capital reports.
Here's what you should know:
1. Motus was founded in 2008. It plans to list on the Nasdaq under the symbol MOTS.
2. Piper Jaffray and Oppenheimer & Co. served as the joint bookrunners.
3. Motus initiated the filing on April 12, 2017.
More article on gastroenterology:
Top 10 states with the highest volume of gastroenterology procedures per ASC
GI leader to know: Dr. Christopher Brown of Atlanta Gastroenterology Associates
Northside Park Gastroenterology and Endoscopy Center owner Dr. Michael Sue to retire — 4 insights